TNFAIP 3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma

[1]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[2]  R. Dong,et al.  Nuclear factor (NF)-κB p65 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-β. , 2015, Life sciences.

[3]  C. Weber,et al.  Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient mice. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[4]  J. Izbicki,et al.  An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer , 2014, Journal of Human Genetics.

[5]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[6]  M. Bhasin,et al.  A20 Regulates Atherogenic Interferon (IFN)-γ Signaling in Vascular Cells by Modulating Basal IFNβ Levels* , 2014, The Journal of Biological Chemistry.

[7]  S. Misra,et al.  Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. , 2014, World journal of gastrointestinal oncology.

[8]  F. Marincola,et al.  IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes , 2013, British Journal of Cancer.

[9]  C. Ferran,et al.  A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL‐6/STAT3 proliferative signals , 2013, Hepatology.

[10]  Ming Wang,et al.  Bladder Polypoid Cystitis-Derived A20 Associates with Tumorigenesis , 2013, Cell Biochemistry and Biophysics.

[11]  A. Ma,et al.  A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.

[12]  H. Kuwano,et al.  TNFAIP8 Overexpression: Clinical Relevance to Esophageal Squamous Cell Carcinoma , 2012, Annals of Surgical Oncology.

[13]  Zi-yu Liu,et al.  Expression of A20 is reduced in pancreatic cancer tissues , 2012, Journal of Molecular Histology.

[14]  Fenggui Wei,et al.  Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells. , 2012, Biochemical and biophysical research communications.

[15]  V. Dixit,et al.  Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. , 2010, Molecular cell.

[16]  C. Dumontet,et al.  A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells , 2007, Oncogene.

[17]  P. Liu,et al.  Gene expression profile of multiple myeloma cell line treated by realgar. , 2006, Journal of experimental & clinical cancer research : CR.

[18]  Soizic Daniel,et al.  A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. , 2004, Blood.

[19]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[20]  M. Jäättelä,et al.  A20 zinc finger protein inhibits TNF-induced apoptosis and stress response early in the signaling cascades and independently of binding to TRAF2 or 14-3-3 proteins , 2001, Cell Death and Differentiation.

[21]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[22]  R. Contreras,et al.  The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases , 1999, Oncogene.

[23]  J. Salisbury,et al.  A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma , 1999, The Journal of pathology.

[24]  D. Goeddel,et al.  The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  V. Dixit,et al.  The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. , 1992, The Journal of biological chemistry.

[26]  M S Boguski,et al.  The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. , 1990, The Journal of biological chemistry.

[27]  F. W. Wolf,et al.  Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. , 1990, The Journal of biological chemistry.

[28]  R. McLendon,et al.  Targeting A 20 Decreases Glioma Stem Cell Survival and Tumor Growth , 2010 .

[29]  R. Contreras,et al.  The Zinc Finger Protein A 20 Inhibits TNF-induced NFk B – dependent Gene Expression by Interfering with an RIP-or TRAF 2-mediated Transactivation Signal and Directly Binds to a Novel NFk B – inhibiting Protein , 1999 .